The aim of the study was to investigate the potential clinical relevance of immunohistochemically assessed RON expression in a large, single institution series of primary untreated advanced ovarian cancer patients.
Ferrandina, M. G., Martinelli, E., Petrillo, M., Prisco, M. G., Zucconi, A., Santaguida, S., Zannoni, G. F., Scambia, G., Ferlini, C., Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients, <<GYNECOLOGIC ONCOLOGY>>, 2008; 111 (2): 237-243. [doi:10.1016/j.ygyno.2008.07.013] [http://hdl.handle.net/10807/31935]
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients
Ferrandina, Maria Gabriella;Martinelli, Enrica;Petrillo, Marco;Santaguida, Salvatore;Zannoni, Gian Franco;Scambia, Giovanni;Ferlini, Cristiano
2008
Abstract
The aim of the study was to investigate the potential clinical relevance of immunohistochemically assessed RON expression in a large, single institution series of primary untreated advanced ovarian cancer patients.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
